KRYS IPOs 4.55M* shares @$10: https://finance.yahoo.com/news/krystal-biotech-announces-pricing-upsized-204702620.html Krystal Biotech, Inc. is a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases. For more information, please visit http://www.krystalbio.com. The IPO price equates to a market cap of $104M* and an EV of $60M, making this one of the smallest biotech IPOs this year. *Assuming exercise of underwriter’s option.